1. Ament, A., & Hasman, A. (1993). Optimal test strategy in the case of two tests and one disease. International Journal of Bio-Medical Computing, 33(3–4), 179–197.
2. Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., Lincoff, A. M., Peterson, E. D., Theroux, P., Wenger, N. K., Wright, R. S., & Smith, S. C. (2011). The ACCF/AHA-focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients’ highly sensitive troponin and coronary computed tomography angiography in the evaluation of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the american college of cardiology foundation/american heart association task force on practice guidelines. Circulation, 123, e426–e579.
3. Bandstein, N., Ljung, R., Johansson, M., & Holzmann, M. J. (2014). Undetectable high-sensitivity cardiac troponin T-level in the emergency department and risk of myocardial infarction. Journal of the American College of Cardiology, 63, 2569–2578.
4. Body, R., Carley, S., McDowell, G., Jaffe, A. S., France, M., Cruickshank, K., Wibberley, C., Nuttall, M., & Mackway-Jones, K. (2011). Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. Journal of the American College of Cardiology, 58, 1332–1339.
5. Ferencik, M., Liu, T., Mayrhofer, T., Puchner, S. B., Lu, M. T., Maurovich-Horvat, P., Pope, J. H., Truong, Q. A., Udelson, J. E., Peacock, W. F., White, C. S., Woodard, P. K., Fleg, J. L., Nagurney, J. T., Januzzi, J. L., & Hoffmann, U. (2015). Highly sensitive troponin I followed by advanced coronary artery disease assessment using computed tomography angiography improves acute coronary syndrome risk stratification accuracy and work-up in acute chest pain patients: Results from ROMICAT II trial. JACC Cardiovascular Imaging, 8, 1272–1281.